canrenone has been researched along with Aldosteronism in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Ceolotto, G; Cesari, M; Maiolino, G; Rossi, GP; Rossitto, G; Seccia, TM | 1 |
| Armanini, D; Boscaro, M; Sabbadin, C | 1 |
| Avataneo, V; Bertello, C; Buffolo, F; Burrello, J; D'Avolio, A; Mengozzi, G; Monticone, S; Mulatero, P; Pecori, A; Rabbia, F; Rumbolo, F; Veglio, F | 1 |
| Camilla, R; Einaudi, S; Monticone, S; Mulatero, P; Mussa, A; Porta, F; Tessaris, D; Verna, F | 1 |
| Claire, M; Corvol, P; Menard, J; Michaud, A; Rafestin-Oblin, ME; Roth-Meyer, C | 1 |
| Appenheimer, M; Glänzer, K; Herschbach, ML; Krück, F; Lucas, R; Vetter, H; Weiand, H; Witassek, F | 1 |
| de Kloet, ER; Sutanto, W | 1 |
2 review(s) available for canrenone and Aldosteronism
| Article | Year |
|---|---|
Spirolactones: clinical and pharmacologic studies.
Topics: Aldosterone; Animals; Binding, Competitive; Canrenoic Acid; Canrenone; Diuresis; Humans; Hyperaldosteronism; Hypertension; In Vitro Techniques; Kidney; Mineralocorticoid Receptor Antagonists; Pregnadienes; Protein Binding; Rats; Receptors, Cell Surface; Spironolactone | 1977 |
Mineralocorticoid receptor ligands: biochemical, pharmacological, and clinical aspects.
Topics: Addison Disease; Adrenal Cortex Hormones; Animals; Brain Chemistry; Canrenone; Drug Design; Hippocampus; Humans; Hyperaldosteronism; Ligands; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Rats; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Steroid; Spironolactone; Structure-Activity Relationship | 1991 |
5 other study(ies) available for canrenone and Aldosteronism
| Article | Year |
|---|---|
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Canrenone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Imidazoles; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Prognosis; Prospective Studies; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles | 2020 |
Primary aldosteronism: considerations about the evaluation of the aldosterone to renin ratio during canrenone treatment.
Topics: Aldosterone; Antihypertensive Agents; Canrenone; Diagnostic Techniques, Endocrine; Duration of Therapy; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System; Reproducibility of Results | 2021 |
Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Topics: Adolescent; Adrenalectomy; Adult; Aged; Aldosterone; Canrenone; Cohort Studies; False Negative Reactions; Female; Guidelines as Topic; Humans; Hyperaldosteronism; Hypertension; Male; Mass Screening; Medication Adherence; Middle Aged; Mineralocorticoid Receptor Antagonists; Potassium; Prospective Studies; Renin; Reproducibility of Results; Young Adult | 2021 |
Polyuric-polydipsic syndrome in a pediatric case of non-glucocorticoid remediable familial hyperaldosteronism.
Topics: Age of Onset; Canrenone; Child, Preschool; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Genotype; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Antagonists; Mutation; Phenotype; Polydipsia; Polyuria; Syndrome | 2012 |
Effect of a spirolactone on plasma and urinary aldosterone in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Canrenone; Female; Glucuronates; Humans; Hyperaldosteronism; Kinetics; Potassium; Pregnadienes; Renin | 1977 |